Deltanoid’s and Abbott’s Renal Partnership
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 51 (Table of Contents)
Published: 4 Sep-2004
DOI: 10.3833/pdr.v2004.i51.780 ISSN: 1756-7874
Section: General
Abstract
Abbott Laboratories and Deltanoid Pharmaceuticals entered into an option and licence agreement to develop novel Vitamin D Receptor Activators (VDRAs) for treating chronic kidney disease...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
Last Issue PDF
RSS